• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical review 75: Recent advances in pathogenesis, diagnosis, and management of acromegaly.

作者信息

Melmed S, Ho K, Klibanski A, Reichlin S, Thorner M

机构信息

Cedars Sinai Research Institute-University of California School of Medicine, Los Angeles 90048, USA.

出版信息

J Clin Endocrinol Metab. 1995 Dec;80(12):3395-402. doi: 10.1210/jcem.80.12.8530571.

DOI:10.1210/jcem.80.12.8530571
PMID:8530571
Abstract
摘要

相似文献

1
Clinical review 75: Recent advances in pathogenesis, diagnosis, and management of acromegaly.临床综述75：肢端肥大症发病机制、诊断及治疗的最新进展
J Clin Endocrinol Metab. 1995 Dec;80(12):3395-402. doi: 10.1210/jcem.80.12.8530571.
2
Pituitary gland: New consensus in acromegaly: criteria for cure and control.垂体：肢端肥大症的新共识：治愈和控制标准
Nat Rev Endocrinol. 2010 Sep;6(9):480-1. doi: 10.1038/nrendo.2010.129.
3
Diagnostic and therapeutic consensus on acromegaly.肢端肥大症的诊断与治疗共识
J Endocrinol Invest. 2005;28(5 Suppl):56-60.
4
American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly--2011 update.美国临床内分泌医师协会肢端肥大症诊断与治疗临床实践医学指南——2011年更新版
Endocr Pract. 2011 Jul-Aug;17 Suppl 4:1-44. doi: 10.4158/ep.17.s4.1.
5
The reason for a Clinical Statement on Acromegaly.关于肢端肥大症的临床声明的原因。
J Endocrinol Invest. 2009;32(6 Suppl):1.
6
Acromegaly: etiology, diagnosis and management.肢端肥大症：病因、诊断与治疗
Compr Ther. 1991 Jul;17(7):31-5.
7
The diagnosis and management of acromegaly: a Canadian consensus report.肢端肥大症的诊断与管理：一份加拿大共识报告。
Clin Invest Med. 1996 Aug;19(4):259-70.
8
The Network for the Enhancement of Endocrinology and Oncology Knowledge: a case-based consideration of current practice in Cushing's disease and acromegaly.内分泌与肿瘤学知识强化网络：基于病例对库欣病和肢端肥大症当前治疗实践的思考
Best Pract Res Clin Endocrinol Metab. 2009 Dec;23 Suppl 1:S1-4. doi: 10.1016/S1521-690X(09)00149-3.
9
Medical management of acromegaly--what and when?
Acta Endocrinol (Copenh). 1993 Jul;129 Suppl 1:13-7.
10
[Croatian Society of Endocrinology guidelines for the diagnosis and treatment of acromegaly].
Lijec Vjesn. 2012 Mar-Apr;134(3-4):65-8.

引用本文的文献

1
[Discordant parameters of insulin-like growth factor 1 and growth hormone in the diagnosis and monitoring of acromegaly].[胰岛素样生长因子1和生长激素在肢端肥大症诊断和监测中的不一致参数]
Probl Endokrinol (Mosk). 2021 Dec 17;68(1):40-48. doi: 10.14341/probl12791.
2
Biochemical investigations in diagnosis and follow up of acromegaly.肢端肥大症诊断与随访中的生化检查
Pituitary. 2017 Feb;20(1):33-45. doi: 10.1007/s11102-017-0792-z.
3
Using growth hormone levels to detect macroadenoma in patients with acromegaly.用生长激素水平检测肢端肥大症患者的大腺瘤。
Endocrinol Metab (Seoul). 2014 Dec 29;29(4):450-6. doi: 10.3803/EnM.2014.29.4.450. Epub 2014 May 27.
4
Gigantism caused by growth hormone secreting pituitary adenoma.由分泌生长激素的垂体腺瘤引起的巨人症。
Ann Pediatr Endocrinol Metab. 2014 Jun;19(2):96-9. doi: 10.6065/apem.2014.19.2.96. Epub 2014 Jun 30.
5
The role of colonoscopic screening in acromegaly revisited: review of current literature and practice guidelines.重新审视结肠镜筛查在肢端肥大症中的作用：当前文献及实践指南综述
Pituitary. 2015 Aug;18(4):568-74. doi: 10.1007/s11102-014-0586-5.
6
Growth hormone, prolactin, and sexuality.生长激素、催乳素与性行为。
J Endocrinol Invest. 2012 Sep;35(8):782-94. doi: 10.1007/BF03345805.
7
Lanreotide Autogel: a review of its use in the management of acromegaly.兰瑞肽长效凝胶：用于肢端肥大症管理的综述
Drugs. 2008;68(5):711-23. doi: 10.2165/00003495-200868050-00013.
8
Management of acromegaly: is there a role for primary medical therapy?肢端肥大症的管理：初级药物治疗是否有作用？
Rev Endocr Metab Disord. 2008 Mar;9(1):83-94. doi: 10.1007/s11154-007-9061-1.
9
A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly.一项前瞻性多中心研究，旨在调查长效重复注射用奥曲肽（奥曲肽LAR）在肢端肥大症患者初始治疗中的疗效、安全性和耐受性。
Clin Endocrinol (Oxf). 2007 Jun;66(6):859-68. doi: 10.1111/j.1365-2265.2007.02825.x. Epub 2007 Apr 25.
10
Efficacy and safety of CyberKnife radiosurgery for acromegaly.射波刀放射外科治疗肢端肥大症的疗效与安全性
Pituitary. 2007;10(1):19-25. doi: 10.1007/s11102-007-0004-3.